BIOMARIN PHARMACEUTICAL INC Insider Trading for March 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOMARIN PHARMACEUTICAL INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOMARIN PHARMACEUTICAL INC for March 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 21 2014 | BMRN | BIOMARIN PHARMACEU ... | Slamon Dennis | Director | Option Exercise | A | 79.70 | 10,000 | 797,000 | 10,000 | |
| Mar 21 2014 | BMRN | BIOMARIN PHARMACEU ... | Slamon Dennis | Director | Grant | A | 0.00 | 4,000 | 0 | 4,700 | 700 to 4.7 K (+571.43 %) |
| Mar 10 2014 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Option Exercise | M | 28.23 | 14,812 | 418,143 | 5,258 | |
| Mar 10 2014 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Option Exercise | M | 21.51 | 2,558 | 55,023 | 3,125 | |
| Mar 10 2014 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Sell | S | 78.63 | 17,370 | 1,365,831 | 25,380 | 42.8 K to 25.4 K (-40.63 %) |
| Mar 10 2014 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Buy | M | 28.23 | 14,812 | 418,143 | 42,750 | 27.9 K to 42.8 K (+53.02 %) |
| Mar 10 2014 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Buy | M | 21.51 | 2,558 | 55,023 | 27,938 | 25.4 K to 27.9 K (+10.08 %) |
| Mar 05 2014 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Option Exercise | M | 39.06 | 8,000 | 312,480 | 71,000 | |
| Mar 05 2014 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Sell | S | 80.32 | 8,000 | 642,530 | 64,273 | 72.3 K to 64.3 K (-11.07 %) |
| Mar 05 2014 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Buy | M | 39.06 | 8,000 | 312,480 | 72,273 | 64.3 K to 72.3 K (+12.45 %) |